Business Context and Reporting Period
This Form 6-K filing by AMBEV S.A. covers the month of March 2018. The report details a corporate action approved by the Board of Directors on March 26, 2018, regarding a capital increase resulting from the exercise of stock options under the company's 2018 Stock Option Plan.
Key Financial Metrics
The filing focuses on capital structure changes rather than operational performance metrics. Key figures include:
- Capital Increase Amount: BRL 26,673,661.96
- New Capital Stock Total: BRL 57,640,813,509.29
- Shares Issued: 1,190,024 new common shares (no par value)
- Issuance Price: BRL 22.3403304128248 per share
- Potential Dilution: 0.0076%
Note: The filing text does not provide values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
The primary material change is the increase in authorized capital stock due to the issuance of 1,190,024 new common shares. This action was taken pursuant to the exercise of options by certain beneficiaries. The filing includes historical market price data for the last three years, two years (quarterly), and six months (monthly), showing an average share price of BRL 22.26 over the last 90 days.
Guidance, Outlook, and Risks
The filing does not contain management commentary on future guidance, outlook, risks, contingencies, or unusual items. It is strictly a notice of capital increase approved under Brazilian Law No. 6,404/76 and the Company's Bylaws.
Investor Verification Checklist
- Verify the impact of the 0.0076% dilution on existing shareholder equity.
- Confirm the total number of outstanding shares post-issuance (New Capital Stock: BRL 57.64 billion).
- Review the specific terms of the "Second Program for the year of 2018 of the Company's Stock Option Plan" for future dilution risks.
- Check subsequent filings for operational financial results, as this 6-K does not contain them.